SOLIGENIX, INC. — Director's Dealing 2008

Dec 3, 2008

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2008-11-26

Reporting Person: CAVAZZA PAOLO (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1190770	Direct
Common Stock	356100	Indirect
Common Stock	16666667	Indirect

Footnotes

F1: Shares directly owned by Chaumiere Consultadoria Servicos SDC Unipessoal L.d.a. ("Chaumiere"), which is an indirect wholly owned subsidiary of Aptafin S.p.A. ("Aptafin"). Aptafin is owned by Paolo Cavazza and members of his family.

F2: Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. (?Pharmaceuticals?). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. (?America?). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. (?International?). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A. ("Sigma Tau"). Paolo Cavazza directly and indirectly owns 38% of Sigma Tau.